Should histologic variants alter definitive treatment of bladder cancer?
- 1 September 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Urology
- Vol. 23 (5), 435-443
- https://doi.org/10.1097/mou.0b013e328363e415
Abstract
The clinical significance of variant histology is controversial and diagnosis is challenging. If variant architecture truly identifies high-risk patients, or those with a differential response to therapy, than treatment algorithms should be altered. This review outlines the current evidence and determines whether histologic variants should indeed alter definitive treatment. For patients with pure squamous cell, adenocarcinoma, or small cell carcinoma, there is clear evidence to alter treatment paradigms. In adenocarcinoma or squamous cell carcinoma, there is a focus on local control and multimodal therapy with radiation. In small cell carcinoma all stages should be treated with primary chemotherapy followed by surgical extirpation. For patients with other variants of urothelial differentiation (i.e., micropapillary, sarcomatoid, squamous/glandular differentiation, etc.), management guidelines are less clear and radical cystectomy remains the mainstay of treatment at this time. The management of variant histology is challenging as it not only depends on accurate diagnosis and staging, but on assumptions regarding sensitivity to multimodal therapy (i.e., chemotherapy, radiation, intravesical agents) based on a handful of retrospective case series. This will need to be the focus of future studies and collaborative efforts in order to make significant advancements in the field.Keywords
This publication has 42 references indexed in Scilit:
- The Sensitivity of Initial Transurethral Resection or Biopsy of Bladder Tumor(s) for Detecting Bladder Cancer Variants on Radical CystectomyJournal of Urology, 2013
- Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcomeBJU International, 2012
- The impact of variant histology on the outcome of bladder cancer treated with curative intentUrologic Oncology, 2009
- Outcome of Patients With Bladder Cancer With pN+ Disease After Preoperative Chemotherapy and Radical CystectomyUrology, 2009
- Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladderWorld Journal of Urology, 2008
- Urothelial Carcinoma with Divergent Histologic Differentiation (Mixed Histologic Features) Predicts the Presence of Locally Advanced Bladder Cancer When Detected at Transurethral ResectionUrology, 2007
- Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasizeHuman Pathology, 2007
- Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: A mapping studyUrology, 2005
- RADICAL CYSTECTOMY FOR PRIMARY NEUROENDOCRINE TUMORS OF THE BLADDER: THE UNIVERSITY OF SOUTHERN CALIFORNIA EXPERIENCEJournal of Urology, 2005
- Small cell carcinoma of the urinary bladderCancer, 2004